Cyclosporine a inhibits TNF production without decreasing TNF mRNA levels
- 31 May 1989
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 161 (2) , 551-555
- https://doi.org/10.1016/0006-291x(89)92634-x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndromeThe American Journal of Medicine, 1988
- TUMOR NECROSIS, CACHEXIA, SHOCK, AND INFLAMMATION: A COMMON MEDIATORAnnual Review of Biochemistry, 1988
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.The Journal of Experimental Medicine, 1987
- Tumor Necrosis Factor (Cachectin) as an Essential Mediator in Murine Cerebral MalariaScience, 1987
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytesJournal of Immunological Methods, 1986
- RAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONSThe Lancet, 1986
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979